• About us
• Contact

Advertisement

Organisation › Details

Cevec Pharmaceuticals GmbH

CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP®GT is a fully scalable manufacturing platform for viral vector production. CEVEC has successfully developed CAP®GT suspension cell-derived viral packaging cell lines, including a stable, helper virus-free AAV production platform, which enable better scale-up and competitive production costs when compared to adherent cell culture systems. CAP®GT suspension cell lines grow to high cell densities and show excellent productivity for a broad range of viruses. Gene therapy vectors such as lentiviral, adenoviral, and adeno-associated viral (AAV) vectors can be produced at industrial scale. CAP®Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP®Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns. *

 

	Start	2001-01-01 established
	Group	Danaher (Group)
	Industry	cell line/system (recombinant protein production)
	Industry 2	CAP® technology (Cevec)
	Person	Faust, Nicole (Cevec 201904 CEO + CSO joined Cevec 201105 before amaxa + Artemis Pharmaceuticals)
	Person 2	Kettling, Ulrich (Cevec 202004 CBO)
	Region	Köln (Cologne)
	Country	Germany
	Street	60-62 Gottfried-Hagen-Str.
	City	51105 Köln
		Address record changed: 2022-09-17
Basic data	Employees	B: 11 to 50 (2022-10-06)
		* Document for »About Section«: Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne.
		Record changed: 2023-12-30

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [2] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [3] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
• [4] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [5] Cevec Pharmaceuticals GmbH. (7/27/21). "Press Release: Cevec Closes Growth Financing Round to Serve Strong Demand in Viral Vector Technologies for Cell and Gene Therapies". Cologne....
• [6] Biognosys AG. (6/15/21). "Press Release: Biognosys Announces New Release of Spectronaut". Schlieren....
• [7] Cytiva. (6/2/21). "Press Release: Cytiva Acquires GoSilico to Strengthen Digital Capabilities in Bioprocessing"....
• [8] Lunaphore Technologies S.A.. (5/13/21). "Press Release: Lunaphore Announces Appointment of Matthias Weber, former President of Leica Biosystems, to Board of Directors". Lausanne....
• [9] Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar....
• [10] Cevec Pharmaceuticals GmbH. (2/2/21). "Press Release: Cevec and Carisma Therapeutics Sign License Agreement for the Use of CAP Technology in Anti-tumor Cell Therapies". Cologne & Philadelphia, PA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.